Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SANUWAVE HealthSNWV -8.02%34 EV-to-FCF is 17.93 as of Jul. 16, 2026. GuruFocus rates SNWV with a GF Score™ of 34/100 and a GF Value™ of $12.05 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 413 Medical Devices & Instruments companies, SANUWAVE Health ranks better than 60.77% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SANUWAVE Health's Enterprise Value is $69.09 Mil.
SANUWAVE Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $3.85 Mil. Therefore, SANUWAVE Health's EV-to-FCF for today is 17.93.
The historical rank and industry rank for SANUWAVE Health's EV-to-FCF or its related term are showing as below:
SNWV'
s EV-to-FCF Range Over the Past 10 Years
Min: -4075.66 Med: -9.05 Max: 596.6
Current: 17.93
During the past 13 years, the highest EV-to-FCF of SANUWAVE Health was 596.60. The lowest was -4075.66. And the median was -9.05.
SNWV's EV-to-FCF is ranked better than 60.77% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs SNWV: 17.93
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SANUWAVE Health's PE Ratio (TTM) for today is calculated as:
SANUWAVE Health's share price for today is $6.71.
SANUWAVE Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.330.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SANUWAVE Health EV-to-FCF Related Terms
SANUWAVE Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SANUWAVE Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's EV-to-FCF falls into.
SANUWAVE Health's current Enterprise Value is $69.09 Mil.
SANUWAVE Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (SNWV) has a EV-to-FCF of 17.93 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SANUWAVE Health and its competitors. According to the industry distribution chart, SANUWAVE Health ranks #162 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 39.2%.
Is SANUWAVE Health's EV-to-FCF too high?
SANUWAVE Health's current EV-to-FCF is 17.93. The Medical Devices & Instruments industry median EV-to-FCF is 23.72. SANUWAVE Health's value of 17.93 is 24.4% below this industry median. Based on the distribution chart, SANUWAVE Health ranks #162 out of 413 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SANUWAVE Health has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's EV-to-FCF compare to RTGN and NNOX?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #162 out of 413 companies for EV-to-FCF. This puts SANUWAVE Health in the upper half of its industry. The industry median EV-to-FCF is 23.72. SANUWAVE Health's value of 17.93 is 24.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current EV-to-FCF of 17.93 is 24.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SANUWAVE Health and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current EV-to-FCF is 17.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $12.05, compared to a current price of $6.71 — trading 44.3% below its estimated fair value. The current EV-to-FCF is 17.93 and 24.4% below the Medical Devices & Instruments industry median of 23.72. SANUWAVE Health's overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current EV-to-FCF is 17.93 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $6.71 is trading 44.3% below its estimated GF Value™ of $12.05.
GuruFocus considers SANUWAVE Health to be Possible Value Trap.
Key valuation signals for SNWV:
EV-to-FCF: 17.93
GF Value™: $12.05 vs. price of $6.71 (44.3% below fair value)
Industry Position: 24.4% below the Medical Devices & Instruments median (#162 of 413)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
34GF Score
Get the complete analysis for SNWV
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
